Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP-U: Ustekinumab on Vascular Inflammation in Psoriasis
NCT02187172Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2014
- Primary completion
- Sep 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ustekinumab in psoriasis, sponsored by University of Pennsylvania. Started Jul 2014; status: completed.
02
Drugs
ustekinumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02187172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187172.